Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Disease Management: Treatment
Benzodiazepines


back to Drugs and Therapies


Important Notice: The Forum does not endorse any medical product or therapy. ALL medications and supplements should be taken ONLY under the supervision of a physician, due to the possibility of side-effects, drug interactions, etc.

Anxiety is a frequent symptom of Alzheimer's disease, affecting over half of the patients in some cohorts.

Benzodiazepines appear efficacious at treating anxiety and insomnia when patients symptomatology lacks psychotic features. Unfortunately, a paradoxical effect has been noted in Alzheimer's patients, in which the administration of benzodiazepines leads to increased confusion, disorientation, and ultimately, even greater agitation and anxiety.

Unfortunately, the experimental evidence to support the use of benzodiazepines in the setting of dementia is very weak.

(see Devanand DP,1997)

Many behavioral "problems" in demented patients are not directly caused by cognitive decline, but instead may be attributed to other factors such as health, medication and physical and social environment. Coexisting illnesses, impaired vision or hearing, psychotropic medications, understimulation or overstimulation, lack of familiar cues in the environment and lack of meaningful activities and social relationships can causes a wide variety of responses in demented patients, including wandering, anxiety, paranoia, difficulty with personal care, incontinence, sleep difficulties and aggression. The Mayo clinic article by Carlson, et al., explains how "problem" behavior is often an attempt to communicate by patients who are losing language and reasoning skills. This useful article lists many nonpharmacologic strategies for managing behavioral disturbances by identifying and addressing the causes.


Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Participate in Research
See a list of research studies, projects, and clinical trials in search of research participants.
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad